Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delavirdine Dose Response Study in HIV-1
NCT00002124Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of delavirdine in human immunodeficiency virus infection (HIV), sponsored by Pfizer. Status: completed.
02
Drugs
delavirdine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002124.